BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Horizon Discovery Enters Into Agreement With Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology

  Under the terms of the agreement, Horizon will develop and provide Reference Standard material expressing NTRK fusion biomarkers.

  December 18, 2017

   · 

  2 min read
• Immunovia Initiates the World’s Largest Study of New-Onset Diabetic Patients in a Prospective Pancreas Cancer Study Supported by Swelife

  Immunova AB today announced the initiation of PanDIA-1, the world’s largest prospective study of the new onset diabetes risk group for pancreatic cancer through a consortium with Lund and Uppsala Universities, Lund University Diabetes Center and Healthcare Region Skåne and Region Uppsala.

  December 18, 2017

   · 

  4 min read
• Artms Products Raises U.S. $3M to Advance a Safe Alternative Way to Locally Produce Medical Isotopes and Avoid Future Supply Disruptions

  The investment comes from Quark Venture and GF Securities, through their Global Health Science Fund, which invests in world-leading health sciences technology platforms and product companies around the world.

  December 18, 2017

   · 

  3 min read
• FDA

  Biom’Up Receives FDA Marketing Approval for HEMOBLAST Bellows, its Flagship Product

  Biom’Up announces today that it has received FDA marketing approval for HEMOBLAST Bellows, its flagship product, 7 months ahead of schedule.

  December 18, 2017

   · 

  4 min read
• Business

  Vir Biotechnology Appoints Leading Immunologist Antonio Lanzavecchia, M.D., Senior VP, Senior Research Fellow

  Reporting to CEO George Scangos, Ph.D., Dr. Lanzavecchia will provide scientific leadership for Vir’s technical programs that are designed to transform the care of people with serious infectious diseases.

  December 18, 2017

   · 

  3 min read
• Business

  Breakout Labs Partners With Science Exchange to Empower its Portfolio Companies With External Research Innovations

  The newly formed partnership allows for Breakout Labs to provide its portfolio companies’ scientists with on-demand access to a global network of research suppliers via the Science Exchange-powered private marketplace.

  December 18, 2017

   · 

  3 min read
• 

  Business

  Neurotrope Poaches Forest Lab Exec to Be CEO

  Dr. Ryan becomes a Director of the Company effective immediately and will assume his responsibilities as CEO effective February 15, 2018.

  December 18, 2017

   · 

  6 min read
• Drug Development

  Novartis Multiple Sclerosis Therapy Fingolimod Granted FDA Breakthrough Therapy Designation for Pediatric MS

  The Breakthrough Therapy designation is based on data from the Phase III PARADIGMS study.

  December 18, 2017

   · 

  13 min read
• Policy

  60° Pharma Submits NDA to U.S. FDA for Antimalarial Drug Tafenoquine

  60 Degrees Pharma as submitted a NDA to the FDA for the use of Tafenoquine to prevent malaria in adults traveling to areas where malaria is prevalent.

  December 18, 2017

   · 

  4 min read
• Business

  Mass Innovation Labs Announces Expansion to NB Development Group’s Boston Landing

  Mass Innovation Labs will occupy 84,000 square feet of the 15-acre mixed-use development that is home to New Balance Athletics, Inc., among other world-class companies and organizations beginning in June of 2018.

  December 18, 2017

   · 

  5 min read